BSC5 Antibody

What is BSC5 Antibody and what organism does it target?

BSC5 Antibody is a polyclonal antibody raised in rabbits against recombinant Saccharomyces cerevisiae (Baker's yeast) BSC5 protein. It specifically targets the BSC5 protein (also known as YNR069C or Bypass of Stop Codon protein 5), which is encoded by the P53755 UniProt entry . This antibody is designed for research applications focused on yeast biology and is not to be confused with antibodies targeting the human ABCB5 protein, which has different biological functions and applications.

What applications is BSC5 Antibody validated for?

BSC5 Antibody has been validated for the following research applications:

• Enzyme-Linked Immunosorbent Assay (ELISA)

• Western Blotting (WB)

The antibody is purified using antigen affinity methods to ensure specificity for the target protein . When selecting this antibody for your research, it's critical to verify that it has been tested in the specific application you intend to use it for, as antibody performance can vary significantly across different experimental techniques .

How should BSC5 Antibody be stored and handled?

For optimal performance and longevity:

• Store at -20°C or -80°C upon receipt

• Avoid repeated freeze-thaw cycles that can degrade antibody quality

• The antibody is supplied in liquid form with a storage buffer containing:

  • 0.03% Proclin 300 (preservative)

  • 50% Glycerol

  • 0.01M PBS, pH 7.4

When handling the antibody, use sterile technique and minimize exposure to room temperature to preserve its binding capacity and specificity.

What is the difference between BSC5 and ABCB5 antibodies?

This is a critical distinction that researchers must understand:

ABCB5 antibodies target a human transmembrane glycoprotein that functions as a multidrug-resistance mediator and cancer stem cell marker, particularly in melanoma. They bind to extracellular epitopes of ABCB5 protein and can inhibit drug-efflux activity. These antibodies should not be confused with BSC5 antibodies despite some search result conflation.

What controls should be included when using BSC5 Antibody?

Proper controls are essential for experimental rigor when using BSC5 Antibody:

• Positive control: Lysate from wild-type S. cerevisiae expressing BSC5

• Negative control: Lysate from BSC5 knockout yeast strain

• Secondary antibody only control: To assess background signal

• Blocking peptide control: Competition assay using the immunizing peptide

• Loading control: For normalization in Western blots (e.g., a housekeeping protein)

The Global Biological Standards Institute highlights that inadequate controls contribute to reproducibility issues in antibody-based research . Including appropriate controls allows researchers to validate specificity and sensitivity of BSC5 antibody reactions.

How can researchers validate BSC5 Antibody specificity?

Antibody validation is critical to ensure experimental reproducibility. For BSC5 Antibody, consider these validation approaches:

• Genetic validation: Compare signal between wild-type and BSC5 knockout yeast

• Orthogonal validation: Correlate protein detection with mRNA expression

• Independent antibody validation: Use multiple antibodies targeting different epitopes

• Expression validation: Test in systems with known BSC5 expression patterns

• Mass spectrometry validation: Confirm identity of immunoprecipitated proteins

Studies estimate that approximately 50% of commercial antibodies fail to meet basic standards for characterization, resulting in billions in research waste annually . Thorough validation of BSC5 Antibody is therefore essential before using it in critical experiments.

What factors influence BSC5 Antibody performance in Western blotting?

When using BSC5 Antibody for Western blotting, consider these technical factors:

• Protein denaturation conditions: The epitope accessibility may be affected by reducing vs. non-reducing conditions

• Transfer efficiency: Optimize transfer parameters for the molecular weight of BSC5

• Blocking conditions: Test different blocking agents (BSA vs. milk) to minimize background

• Antibody dilution: Determine optimal concentration through titration experiments

• Incubation time and temperature: These can significantly impact signal-to-noise ratio

The detection method should be selected based on sensitivity requirements, with options including chemiluminescence, fluorescence, or colorimetric detection .

How can BSC5 Antibody be used in multi-parameter experiments?

For advanced multi-parameter experiments:

• Multiplexed fluorescent Western blotting: When combining BSC5 detection with other proteins, ensure:

  • Secondary antibodies are raised in different species

  • Fluorophores have non-overlapping emission spectra

  • Sequential rather than simultaneous detection if cross-reactivity occurs

• Co-immunoprecipitation studies:

  • Use gentle lysis conditions to preserve protein-protein interactions

  • Cross-validate interactions with reverse co-IP experiments

  • Consider proximity ligation assays for in situ interaction studies

• Flow cytometry applications:

  • Requires permeabilization for intracellular yeast protein detection

  • Optimization of fixation protocol to preserve epitope recognition

These advanced applications require rigorous validation and optimization, as described in antibody characterization guidelines discussed in scientific forums .

What troubleshooting approaches are recommended for non-specific binding issues?

When encountering non-specific binding with BSC5 Antibody:

• Increased stringency washing:

  • Include higher concentrations of detergent (0.1-0.5% Tween-20)

  • Add low concentrations of SDS (0.01-0.05%) to wash buffers

  • Increase salt concentration (up to 500mM NaCl) in wash buffers

• Blocking optimization:

  • Test alternative blocking agents (BSA, milk, commercial blockers)

  • Extend blocking time from 1 hour to overnight at 4°C

  • Add 0.1-0.5% Tween-20 to blocking solution

• Antibody dilution optimization:

  • Test serial dilutions to identify optimal concentration

  • Prepare antibody dilutions in blocking buffer with 0.1% Tween-20

  • Consider overnight incubation at 4°C rather than shorter incubations

• Sample preparation modifications:

  • Add reducing agents to disrupt non-specific disulfide bonds

  • Pre-clear lysates with Protein A/G beads

  • Use fresher antibody aliquots to avoid degradation products

These approaches align with recommendations for enhancing reproducibility in antibody-based research .

How does the polyclonal nature of BSC5 Antibody affect experimental design?

The polyclonal nature of BSC5 Antibody has important implications:

• Epitope recognition: Polyclonal antibodies recognize multiple epitopes, which can be advantageous for detection but may increase cross-reactivity risk .

• Lot-to-lot variability: Each production lot may have different epitope recognition patterns, requiring:

  • Validation of each new lot before critical experiments

  • Maintenance of detailed records of lot numbers used in each experiment

  • Consideration of purchasing larger lots for long-term projects

• Quantification considerations: For quantitative applications:

  • Standard curves should be created with each lot

  • Signal intensity may vary between lots even with identical protein amounts

  • More stringent validation is needed for precise quantitative studies

The antibody characterization crisis highlighted in scientific literature emphasizes the importance of understanding these limitations when designing experiments with polyclonal antibodies like BSC5 Antibody .

How does BSC5 Antibody research interface with broader immunological studies?

While BSC5 Antibody targets a yeast protein, its research applications can provide insights relevant to broader immunological principles:

• Comparative immunology: Studying antigen recognition across species can illuminate evolutionary conservation of immunological mechanisms.

• Methodological transfer: Techniques optimized for BSC5 detection may be adaptable to human immunological studies, such as those involving ABCB5+ dermal immunoregulatory cells (DIRCs) .

• Cross-disciplinary applications: Understanding BSC5 function in yeast can inform research on:

  • Protein translation termination mechanisms

  • Genetic code maintenance

  • Evolutionary conservation of cellular processes

This cross-disciplinary approach reflects recent findings that B cells have more complex roles than previously recognized, including localized functions at inflammation sites and in tumor microenvironments .

What bioinformatic approaches can enhance BSC5 Antibody experimental design?

Advanced bioinformatic analysis can significantly improve BSC5 Antibody experimental design:

• Epitope prediction:

  • In silico analysis of BSC5 protein sequence for likely epitopes

  • Cross-species homology assessment to predict potential cross-reactivity

  • Secondary structure prediction to identify accessible epitopes

• Systems biology integration:

  • Network analysis incorporating BSC5 protein interactions

  • Pathway enrichment analysis to contextualize BSC5 function

  • Multi-omics data integration (proteomics, transcriptomics, metabolomics)

• Machine learning applications:

  • Prediction of optimal experimental conditions based on protein properties

  • Automated image analysis for immunohistochemistry or immunofluorescence

  • Pattern recognition in complex datasets involving BSC5

These computational approaches align with modern trends in antibody research that emphasize comprehensive characterization and validation .

How might synthetic biology approaches enhance BSC5 Antibody research?

Emerging synthetic biology techniques offer new possibilities for BSC5 research:

• Recombinant antibody engineering:

  • Converting polyclonal BSC5 antibodies to defined recombinant formats

  • Engineering single-chain variable fragments (scFvs) for improved tissue penetration

  • Creating bispecific antibodies to simultaneously target BSC5 and interaction partners

• CRISPR-based validation:

  • Generating precise knockout models for antibody validation

  • Creating epitope-tagged endogenous BSC5 for antibody-independent detection

  • Implementing CRISPRi for titratable knockdown studies

• Protein display technologies:

  • Phage display for mapping precise epitopes recognized by BSC5 Antibody

  • Yeast surface display for quantitative binding measurements

  • Cell-free display systems for high-throughput interaction studies

These approaches address concerns raised about reproducibility in antibody research by providing more precisely defined reagents .

What considerations apply when integrating BSC5 Antibody data with tertiary lymphoid structure research?

Recent findings about B cells forming tertiary lymphoid structures in tissues suggest potential approaches for integrating BSC5 research:

• Comparative structural biology:

  • Examine structural homology between yeast BSC5 and mammalian proteins in tertiary lymphoid structures

  • Investigate whether functional parallels exist in protein complex formation

• Methodological translation:

  • Techniques optimized for BSC5 detection might inform approaches for studying tissue-resident B cells

  • Multiplex imaging protocols may be adaptable across research domains

• Immunological principles:

  • Understanding antibody-antigen interactions in different contexts can provide universal principles

  • Research on B cell biology in tertiary lymphoid structures may provide conceptual frameworks for other immune environments

This integration reflects the value of cross-disciplinary approaches in modern immunological research, as highlighted in recent reviews .